In this paper, albuminuria (defined as albumin concentration in urine >40 mg/L) has been found to be a putative indicator of urinary tract pathologies, and it should be considered as a future rapid morbidity assessment tool to be used in conjunction with urine-reagent strips (e.g. Hemastix) for the screening and monitoring of urinary schistosomiasis, as well as associated chronic morbidity, before and during interventions, especially where ultrasonography may not be possible. This evidence concerns the gene ALB and urinary schistosomiasis.